---
title: "BRO: Q2 2026 revenue up 30.4% and net income up 24.7%, driven by acquisitions and contingents"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293976020.md"
description: "Q2 2026 revenues rose 30.4% year-over-year to $1.68 billion, with net income up 24.7% to $288 million. Growth was driven by acquisitions and higher contingent commissions, while organic revenue with contingents grew 0.7%. Retail segment outperformed Specialty Distribution, and liquidity remains strong.Original document: Brown & Brown, Inc. [BRO] SEC 10-Q Quarterly Report — Jul. 28 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-07-27T21:10:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293976020.md)
  - [en](https://longbridge.com/en/news/293976020.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293976020.md)
generator: "portal-rs"
---

# BRO: Q2 2026 revenue up 30.4% and net income up 24.7%, driven by acquisitions and contingents

Q2 2026 revenues rose 30.4% year-over-year to $1.68 billion, with net income up 24.7% to $288 million. Growth was driven by acquisitions and higher contingent commissions, while organic revenue with contingents grew 0.7%. Retail segment outperformed Specialty Distribution, and liquidity remains strong.

Original document: Brown & Brown, Inc. \[BRO\] SEC 10-Q Quarterly Report — Jul. 28 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [BRO.US](https://longbridge.com/en/quote/BRO.US.md)

## Related News & Research

- [Brown provides investor presentation outlining 2025 results, liquidity and growth strategy](https://longbridge.com/en/news/298576474.md)
- [UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Cuts Holdings in Brown & Brown, Inc. $BRO](https://longbridge.com/en/news/297759500.md)
- [Labcorp buys MLM Medical Labs](https://longbridge.com/en/news/298332531.md)
- [Calviks revises Q2 organic growth to 5.66% from 2.84%](https://longbridge.com/en/news/298204820.md)
- [Chapters Group lifts FY2026 organic adjusted operating EBITDA growth outlook to high-30% range](https://longbridge.com/en/news/298288959.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**